Insider Selling: NEXGEL, Inc. (NASDAQ:NXGL) CEO Sells 4,000 Shares of Stock

by · The Cerbat Gem

NEXGEL, Inc. (NASDAQ:NXGL – Get Free Report) CEO Adam R. Levy sold 4,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 1st. The stock was sold at an average price of $3.01, for a total transaction of $12,040.00. Following the transaction, the chief executive officer now directly owns 370,284 shares of the company’s stock, valued at $1,114,554.84. This represents a 1.07 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

NEXGEL Stock Down 6.3 %

NASDAQ:NXGL opened at $2.67 on Friday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.51 and a quick ratio of 0.93. The company’s fifty day moving average price is $3.14 and its 200-day moving average price is $3.27. NEXGEL, Inc. has a 1-year low of $1.84 and a 1-year high of $5.10. The firm has a market capitalization of $18.13 million, a P/E ratio of -4.60 and a beta of 0.62.

NEXGEL (NASDAQ:NXGL – Get Free Report) last released its quarterly earnings data on Monday, March 24th. The company reported ($0.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.02. The business had revenue of $3.04 million during the quarter, compared to analyst estimates of $2.99 million. NEXGEL had a negative return on equity of 71.19% and a negative net margin of 52.60%.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Virtu Financial LLC purchased a new stake in NEXGEL during the fourth quarter worth $48,000. IFP Advisors Inc acquired a new stake in shares of NEXGEL during the 4th quarter valued at about $49,000. Two Sigma Securities LLC purchased a new position in shares of NEXGEL in the 4th quarter valued at about $54,000. Geode Capital Management LLC raised its holdings in NEXGEL by 5.8% in the 4th quarter. Geode Capital Management LLC now owns 60,142 shares of the company’s stock worth $268,000 after purchasing an additional 3,302 shares during the period. Finally, Renaissance Technologies LLC boosted its position in NEXGEL by 456.4% during the fourth quarter. Renaissance Technologies LLC now owns 158,331 shares of the company’s stock worth $706,000 after purchasing an additional 129,876 shares in the last quarter. 2.21% of the stock is owned by institutional investors and hedge funds.

NEXGEL Company Profile

(Get Free Report)

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.

Featured Articles